Blood transfusions are commonly used to treat a variety of conditions, but their effect on premature infants with severe thrombocytopenia is a topic that has generated much controversy. Studies indicate that blood transfusions can have a significant impact on the survival and development of these highly vulnerable patients.

Thrombocytopenia is a condition in which the platelet count is significantly lower than normal. This condition is particularly dangerous in premature infants, who have insufficient platelet count and function. This leads to an increased risk of bleeding, which can be fatal.

A study of premature infants with severe thrombocytopenia showed that blood transfusions can significantly improve the survival of these patients. A multi-year analysis of the data showed that premature infants who received blood transfusions had higher survival rates compared to those who did not receive transfusions.

In addition to improving survival rates, blood transfusions also have a beneficial effect on the development of premature infants with severe thrombocytopenia. Studies have shown that blood transfusions improve the neurological development and cognitive ability of these patients. Children who received transfusions performed better on cognitive tests than those who did not receive transfusions.

However, it should be emphasized that blood transfusions are not without risks. There is the possibility of complications related to the blood transfusion itself, such as allergic reactions, excessive iron supply or infections. Therefore, it is crucial to carefully assess the risks and benefits before conducting a transfusion. This is a decision that is made by a team of doctors, taking into account the individual needs of the patient.

It is also worth noting that blood transfusions are not always the only possible treatment for premature infants with severe thrombocytopenia. There are also alternative treatments, such as pharmacotherapy, which can be just as effective and less invasive.

It is also important to consider the ethical aspects of blood transfusion in premature infants. The decision to give a transfusion must follow the principles of evidence-based medicine, while respecting the patient's right and principles of autonomy.

In conclusion, blood transfusions have a significant impact on the survival and development of premature infants with severe thrombocytopenia. Scientific studies confirm that blood transfusions improve the survival rate and neurological and cognitive development of these patients. The decision to give blood transfusions should be carefully considered, taking into account the benefits and risks of the procedure and alternative treatments.